Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:16-0079.
doi: 10.1530/EDM-16-0079. Epub 2016 Nov 17.

Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog

Affiliations

Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog

Chih-Ting Su et al. Endocrinol Diabetes Metab Case Rep. 2016.

Abstract

Insulin antibodies (IA) associated with exogenous insulin administration seldom caused hypoglycemia and had different characteristics from insulin autoantibodies (IAA) found in insulin autoimmune syndrome (IAS), which was first described by Dr Hirata in 1970. The characteristic of IAS is the presence of insulin-binding autoantibodies and related fasting or late postprandial hypoglycemia. Here, we report a patient with type 1 diabetes mellitus under insulin glargine and insulin aspart treatment who developed recurrent spontaneous post-absorptive hyperinsulinemic hypoglycemia with the cause probably being insulin antibodies induced by exogenous injected insulin. Examinations of serial sera disclosed a high titre of insulin antibodies (33%, normal <5%), high insulin concentration (111.9 IU/mL) and undetectable C-peptide when hypoglycemia occurred. An oral glucose tolerance test revealed persistent high serum levels of total insulin and undetectable C-peptide. Image studies of the pancreas were unremarkable, which excluded the diagnosis of insulinoma. The patient does not take any of the medications containing sulfhydryl compounds, which had been reported to cause IAS. After administering oral prednisolone for 3 weeks, hypoglycemic episodes markedly improved, and he was discharged smoothly.

Learning points: Insulin autoimmune syndrome (IAS) or IAS-like situation should be one of the differential diagnosis in patients with hyperinsulinemic hypoglycemia.Although less reported, insulin antibodies (IA) caused by exogenous insulin analog should be considered as the cause of hypoglycemia.Patients with suspected insulin autoimmune syndrome (IAS) should be screened for drugs related to autoimmunity to endogenous insulin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A 48-h blood glucose profile revealed early morning hypoglycemia. Black arrows indicate meal ingestion.
Figure 2
Figure 2
After a 75 g glucose load, total insulin remained in high level until 5 h, indicating a relatively delayed clearance. At 5 h after load, blood glucose 45 mg/dL with insulin 97.9 IU/mL. Glucose (solid diamonds) and total insulin (solid squares).

References

    1. Cavaco B, Uchigata Y, Porto T, Amparo-Santos M, Sobrinho L, Leite V. 2001. Hypoglycaemia due to insulin autoimmune syndrome: report of two cases with characterisation of HLA alleles and insulin autoantibodies. European Journal of Endocrinology 145 311–316. (10.1530/eje.0.1450311) - DOI - PubMed
    1. Uchigata Y, Tokunaga K, Nepom G, Bannai M, Kuwata S, Dozio N, Benson EA, Ronningen KS, Spinas GA, Tadokoro K, et al. 1995. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata’s disease) and monoclonal insulin autoimmune syndrome. Diabetes 44 1227–1232. (10.2337/diab.44.10.1227) - DOI - PubMed
    1. Ishizuka T, Ogawa S, Mori T, Nako K, Nakamichi T, Oka Y, Ito S. 2009. Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. Diabetes Research and Clinical Practice 84 e21–e23. (10.1016/j.diabres.2009.02.007) - DOI - PubMed
    1. Matsuyoshi A, Shimoda S, Tsuruzoe K, Taketa K, Chirioka T, Sakamoto F, Sakakida M, Miyamura N, Araki E. 2006. A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy. Diabetes Research and Clinical Practice 72 238–243. (10.1016/j.diabres.2005.10.018) - DOI - PubMed
    1. Wredling R, Lins PE, Adamson U. 1990. Prevalence of antiinsulin antibodies and its relation to severe hypoglycaemia in insulin-treated diabetic patients. Scandinavian Journal of Clinical and Laboratory Investigation 50 551–557. (10.1080/00365519009089170) - DOI - PubMed

LinkOut - more resources